Strategic partnerships Potential collaboration with large chemical and materials players (e.g., SABIC and related ventures) to scale Molecular Rebar technology, leveraging MRD’s CNT solutions for high-value applications and joint development opportunities.

High-value markets Target sectors include automotive EVs, defense health, and advanced materials where organosilane functionalized CNTs and carbon nanotube-enabled therapies offer differentiating performance, aligning with contract and SBIR program interests.

SBIR and grants Strong leverage point through SBIR Phase II opportunities with DOE and DoD, presenting potential funding-backed pilot programs and co-development deals to de-risk early-stage customer engagements.

Limited scale signals Revenue below $1M and a small employee base present both a challenge and an upside for fast agility in pilots; position as a nimble partner for large buyers seeking innovative CNT-enabled solutions with demonstrated university and industry backing.

Technology credibility Disentangled Molecular Rebar CNT technology and existing patent-pending status, plus a track record of industry recognition and collaborations, can be used to credentialize pitches to R&D leads seeking differentiated materials and therapies.